×
Log in
Upload File
Most Popular
Study
Business
Design
Technology
Travel
Explore all categories
Download -
· Vasi hea documentului ,XALKORI (crizotinib) 200mg si 250 mg capsule pentru administrare orala.lncluderea unei noi atentionari referitoare la insuficienta
Download
Transcript
Page 1
Page 2
Page 3
Page 4
Page 5
LOAD MORE
Top Related
CRIZOTINIB EN CANCER DE PULMÓN NO MICROCÍTICO: …
Xalkori® crizotinibe I - IDENTIFICAÇÃO DO … · LLD_Bra_CDSv22.0_22Jan2018_v2_XALCAP_20_VPS 10/Jul/2018 1 Xalkori® crizotinibe . I - IDENTIFICAÇÃO DO MEDICAMENTO . Nome comercial:
cMET inhibitor crizotinib impairs angiogenesis and reduces tumor
MÉDICAMENTS CIBLANT ALK : CRIZOTINIB, CÉRITINIB
cardiaca aparuta la... · includerea unei noi atentionari referitoare la insuficienta cardiaca aparuta la pacientii tratati cu medicamentul XALKORI (crizotinib). Vä rugäm sä luati
Avelumab (anti PD-L1) in combination with crizotinib or ... · Avelumab (anti–PD-L1) in combination with crizotinib or lorlatinib in patients with previously treated advanced NSCLC:
Attachment: Product Information: Crizotinib · Web viewAttachment 1: Product information AusPAR Xalkori Pfizer Australia Pty Ltd PM-2016-03535-1-4 Final 18 October 2018.This Product
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS...Table 1. XALKORI dose modification – haematological toxicitiesa,b CTCAEc Grade XALKORI treatment Grade 3 Withhold until recovery to Grade